TP53 and acne: Subsequent investigations revealed that despite the use of different pharmacological agents targeting distinct acne pathogenesis mechanisms, a synergistic mode of action was observed, characterized by the attenuation of the AKT/mTORC1 signaling and enhancement of p53 signaling [42].